The abstract is read at the publisher; the summary is JClub's.
HPV-DeepSeek, a whole-genome HPV liquid biopsy, detects HPV+ cancers with 99% sensitivity and specificity and classifies viral physical state from plasma at diagnosis.
- Why it matters: ctHPVDNA assays have limited prognostic value at diagnosis and cannot determine whether HPV is episomal or integrated, despite integration predicting poor outcomes in tissue.
- What they did: In a cohort of 235 HPV+ cancers across 9 anatomic sites, the team validated HPV-DeepSeek’s diagnostic accuracy and used HPV-SIGNAL to infer physical state from plasma, then confirmed it with three orthogonal tissue and blood approaches.
- The result: Among 189 eligible samples, integrated viral states in blood (episomal-only n=71; episomal-rearranged n=52; integrated-mixed n=57; integrated-clonal n=9) were linked to worse progression-free survival (HR 2.78, 95% CI 1.30–5.99; P=0.009) and overall survival (HR 2.95, 95% CI 1.01–8.61; P=0.048) versus episomal states.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.